The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
S-nitrosoglutathione reductase (GSNOR), or ADH5, is an enzyme in the alcohol dehydrogenase (ADH) family. It is unique when compared to other ADH enzymes in that primary short-chain alcohols are not its principle substrate. GSNOR metabolizes S-nitrosoglutathione (GSNO), S-hydroxymethylglutathione (the spontaneous adduct of formaldehyde and glutathione), and some alcohols. GSNOR modulates reactive nitric oxide (•NO) availability in the cell by catalyzing the breakdown of GSNO, and indirectly regulates S-nitrosothiols (RSNOs) through GSNO-mediated protein S-nitrosation. The dysregulation of GSNOR can significantly alter cellular homeostasis, leading to disease. GSNOR plays an important regulatory role in smooth muscle relaxation, immune function, inflammation, neuronal development and cancer progression, among many other processes. In recent years, the therapeutic inhibition of GSNOR has been investigated to treat asthma, cystic fibrosis and interstitial lung disease (ILD). The direct action of •NO on cellular pathways, as well as the important regulatory role of protein S-nitrosation, is closely tied to GSNOR regulation and defines this enzyme as an important therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reactive oxygen species: Metabolism, oxidative stress, and signal transduction
Apel, K., & Hirt, H. (2004) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.55.031903.141701 · Cited by 11,723 · cited 1×
“Decades of research have left little question as to detrimental effects of oxidative/nitrosative stress (DalleDonne et al., 2006; Guzik et al., 2002; M€unzel et al., 1997), and the mechanistic underpinnings of this process have been thoroughly investigated (Apel & Hirt, 2004; Valko et al., 2007).”
BackgroundThe L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Protein S-nitrosylation: Purview and parameters
Hess, D. T., Matsumoto, A., Kim, S.-O., Marshall, H. E., & Stamler, J. S. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1569 · Cited by 2,153 · cited 2×
“It is also well known that S-nitrosation can vary significantly based upon the cytoplasmic availability GSNOR (Broniowska & Hogg, 2012; Hess et al., 2005; Thomas & Jourd’heuil, 2012).”
BackgroundBiomarkers of Oxidative Damage in Human Disease
Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703
Wink, D. A., & Mitchell, J. B. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00092-6 · Cited by 1,606
A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans
Liu, L., Hausladen, A., Zeng, M., Que, L., Heitman, J., & Stamler, J. S. (2001) · Nature · doi:10.1038/35068596 · Cited by 913 · cited 10×
“Since there are no FDA-approved GSNOR inhibitors, the repurposing of existing therapeutic agents that inhibit GSNOR and/or modulate GSNO and RSNOs is of interest.”
BackgroundInfluentialNitric oxide in health and disease of the respiratory system
Ricciardolo, F. L. M., Sterk, P. J., Gaston, B., & Folkerts, G. (2004) · Physiological Reviews · doi:10.1152/physrev.00034.2003 · Cited by 903 · cited 4×
“…of this figure at www.tandfonline.com/ibmg). plays a critical role in smooth muscle relaxation (Bradley et al., 1998; Buxton, 2004; Liu et al., 2016; Ricciardolo et al., 2004; Tomita et al., 2002) cardiopulmonary regulation (Rastaldo et al., 2007; Sears et al., 2004; Tamargo et al., 2010),…”
BackgroundInfluentialPeroxynitrite reactivity with amino acids and proteins
Alvarez, B., & Radi, R. (2003) · Amino Acids · doi:10.1007/s00726-003-0018-8 · Cited by 560 · cited 1×
“Not only does oxidative stress commandeer available NO and GSH (Rahman & MacNee, 2000), but peroxynitrite can cross the cell membrane and react directly with protein thiols (Alvarez & Radi, 2003), which may prevent S-nitrosation.”
BackgroundS-Nitrosation of the Insulin Receptor, Insulin Receptor Substrate 1, and Protein Kinase B/Akt
Carvalho-Filho, M. A., Ueno, M., Hirabara, S. M., Seabra, A. B., Carvalheira, J. B. C., de Oliveira, M. G., Velloso, L. A., Curi, R., & Saad, M. J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.959 · Cited by 277 · cited 1×
“Some of these include: Type 2 diabetes (Carvalho-Filho et al., 2005), sickle cell anemia (Bonaventura et al., 1999, 2002), ventricular arrhythmia in individuals with the Duchenne muscular dystrophy (Fauconnier et al., 2010), cell death and survival pathways (Iyera et al., 2011), post-infarct…”
Background
Cited by
Pinho, N., Bombaça, A. C., Wiśniewski, J. R., Dias-Lopes, G., Saboia-Vahia, L., Cupolillo, E., de Jesus, J. B., de Almeida, R. P., Padrón, G., Menna-Barreto, R., et al. (2022) · Antioxidants · doi:10.3390/antiox11020277 · Cited by 21
“Alcohol dehydrogenase class III enzymes have GSNO reductase activity and function as a protection against nitrosative stress [39,40].”
Background
Metadata
- Authors
- Barnett, S. D., & Buxton, I. L. O.
- Venue
- Critical Reviews in Biochemistry and Molecular Biology
- Publisher
- Informa UK Limited
- Published
- 2017-04-10
- Volume
- 52
- Issue
- 3
- Pages
- 340-354
- ISSN
- 0045-6411 (ISSN-L)
- 1040-9238
- 1549-7798
- OpenAlex
- W2607510433
- Cited by
- 169
- References
- 19
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy. https://app.cochat.ai/papers/10.1080/10409238.2017.1304353
- The paper
- Barnett, S. D., & Buxton, I. L. O. (2017). The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy. Critical Reviews in Biochemistry and Molecular Biology. https://doi.org/10.1080/10409238.2017.1304353
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.